Amazon appoints leader of new pharmacy business

Amy Baxter | | Health Exec | Management

Months after acquiring online pharmacy PillPack for approximately $1 billion, Amazon has appointed a 14-year veteran with the company to lead its new pharmacy business, CNBC reported. Nader Kabbani has been named vice president of consumables, special projects.

The PillPack team reports to Kabbani, CNBC reported. Kabbani previously worked on Amazon’s Kindle platform and was vice president in the company’s Flex and logistics businesses. The pharmacy business represents a significant opportunity for Amazon as it continues to branch into new industries, particularly healthcare.

Amazon continues its push into the pharmacy business, and has appointed a 14-ye…

“With PillPack, Amazon is poised to take a slice of the growing home delivery market, though it could also potentially incorporate retail pharmacy offerings at Whole Foods locations, after buying the upscale grocery chain for more than $13 billion in 2017,” CNBC reported.

Amazon’s impact on the space has already been apparent, with stocks of other major pharmacies dropping at the time the company acquired PillPack.

See the full story below:

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

FDA issues Class I recall on insertion tubes after manufacturing error
FDA recalls brain biopsy needles due to stainless steel debris
Michigan doctor claims he was fired for reporting unnecessary pacemaker surgeries
Asante Medical facing $488M in lawsuits after fentanyl diversion linked to 16 deaths
FDA issues Class I alert on Philips ventilators after 4 injuries
Trump selects Emmy-winning TV personality Dr. Oz to head CMS

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”